US equities
|
SPCX
$163.15
▲+10.39%
MU
$912.91
▲+1.88%
TSLA
$386.81
▲+3.51%
NVDA
$220.39
▲+1.81%
SNDK
$1,384.39
▲+1.39%
META
$711.01
▲+2.41%
GOOGL
$333.10
▼-2.11%
AAPL
$343.99
▲+1.32%
SPCX
$163.15
▲+10.39%
MU
$912.91
▲+1.88%
TSLA
$386.81
▲+3.51%
NVDA
$220.39
▲+1.81%
SNDK
$1,384.39
▲+1.39%
META
$711.01
▲+2.41%
GOOGL
$333.10
▼-2.11%
AAPL
$343.99
▲+1.32%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Steven Pfanstiel
Recent news which mentions Steven Pfanstiel
Lab Notes: Marinus secures $32M financing; FDA delays decision on Amicus application
November 04, 2022
Tickers
INNO
Tags
Amicus Therapeutics
Zynerba Pharmaceuticals Inc/
Tia Lyles/Williams
From
Business Journals
Marinus selling rare pediatric disease priority review voucher for $110M
July 14, 2022
Tags
Novo Nordisk A/S
Steven Pfanstiel
Marinus Pharmaceuticals Inc/
From
Business Journals